Industry

Biotechnology

Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.

Total Companies
1 319
Biotechnology Industry
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Abbvie Inc
NYSE:ABBV
Loading...
14% Overvalued
67 / 100
29 / 100
$340B
Amgen Inc
NASDAQ:AMGN
Loading...
11% Overvalued
61 / 100
24 / 100
$158.9B
Gilead Sciences Inc
NASDAQ:GILD
Loading...
3% Overvalued
65 / 100
55 / 100
$137.1B
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Loading...
33% Overvalued
61 / 100
95 / 100
$120.9B
CSL Ltd
ASX:CSL
Loading...
2% Overvalued
54 / 100
61 / 100
$76.9B
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Loading...
14% Undervalued
58 / 100
97 / 100
$61B
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Loading...
22% Overvalued
50 / 100
43 / 100
$41.3B
argenx SE
XBRU:ARGX
Loading...
2% Overvalued
53 / 100
99 / 100
$34B
Beigene Ltd
SSE:688235
Loading...
4% Undervalued
32 / 100
73 / 100
$28.6B
Celltrion Inc
KRX:068270
Loading...
10% Undervalued
47 / 100
72 / 100
$27.8B
Beigene Ltd
HKEX:6160
Loading...
12% Undervalued
32 / 100
73 / 100
$27.2B
BioNTech SE
NASDAQ:BNTX
Loading...
67% Overvalued
50 / 100
75 / 100
$27B
Natera Inc
NASDAQ:NTRA
Loading...
55% Overvalued
29 / 100
74 / 100
$22.1B
Biogen Inc
NASDAQ:BIIB
Loading...
24% Undervalued
54 / 100
61 / 100
$19.6B
Summit Therapeutics Inc
NASDAQ:SMMT
Loading...
N/A
21 / 100
69 / 100
$18.6B
Insmed Inc
NASDAQ:INSM
Loading...
4% Overvalued
39 / 100
30 / 100
$18B
Alteogen Inc
KOSDAQ:196170
Loading...
28% Overvalued
63 / 100
95 / 100
$17.1B
Innovent Biologics Inc
HKEX:1801
Loading...
45% Overvalued
39 / 100
60 / 100
$16.8B
Genmab A/S
CSE:GMAB
Loading...
42% Undervalued
66 / 100
99 / 100
$13.7B
United Therapeutics Corp
NASDAQ:UTHR
Loading...
3% Overvalued
69 / 100
93 / 100
$13.4B
Load More